You are here

  • Home
  • Archive
  • Volume 8, Issue 9
  • Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS)

Citation Tools

Article menu

Download PDFPDF

XML
Neurology
Protocol
Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Yamada S, Hashizume A, Hijikata Y, et al
Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS)
BMJ Open 2018;8:e023041. doi: 10.1136/bmjopen-2018-023041